Abbott Presents Results of TriClip Device and Navitor TAVI System for Tricuspid Regurgitation & Aortic Stenosis at EuroPCR 2022

Shots:

The 30-day results from the TriClip (bRIGHT) study of TriClip & TriClip G4 TEER systems showed a high implant success rate (98%), TR reduction (71% vs 3% as baseline), 78% achieved NYHA Functional Class I/II, improvement by 57% from a baseline of 21% & 18-point improvement in KCCQ score
The 1yr. results of the Navitor TAVI system showed the safety, effectiveness & durable response for sev. AS, 97.5% high procedural success rate, high rate of no/trace PVL (70.2%) & low rate of mild PVL & all-cause mortality (28.8% & 4.2%) indicating the active sealing cuff & effective in mitigating PVL
The company highlighted the new results from the (EXPAND) study for MitraClip in HF patients with MR  & Amplatzer Amulet for AF

Ref: Abbott | Image: Abbott